AllQuantitative Report
logoArgusOctober 15, 2020

ENDP: Rating increased to a HOLD

Symbols
ENDP
Sector(s)
Healthcare
Rating
Premium
Current Price
$5.30
Price Target
$NaN
Earnings Estimate
Premium
Summary

After a string of acquisitions and divestitures, Endo is a specialty pharmaceutical company with a considerable presence in pain management. The acquisitions of Auxilium and Par increased the company's presence in urology and generics, respectively.

Premium
Subscribe to Yahoo Finance Premium for full access
Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.
Try Premium FREE